HIGHLIGHTS
- who: Kangdi Yang and collaborators from the Washington University in StLouis, United States have published the research: Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy, in the Journal: (JOURNAL)
- what: The authors propose combining CAR-immune cell therapy with other anti-tumor therapies to help improve the anti-tumor effect, inhibit toxicity, and improve the prognosis of patients .
SUMMARY
CAR-modified NK cell therapy, similar to CAR-T_cell therapy, involves the expression of synthetic receptors by genetically modified immune cells; these immune cells are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.